自己株式の取得、Transfer To Other Capital Surplus From Capital Stock、研究開発費他1件
- 【期間】
| 年度 | 自己株式の取得 | Transfer To Other Capital Surplus From Capital Stock | 研究開発費 | 負債の部合計 |
|---|
| 2008/03 | -10.4億 | | - | | 1.43億 | | 141億 | |
| 2009/03 | -11.4億 | 赤拡 | - | | 0.85億 | -40.6% | 145億 | +2.6% |
| 2010/03 | -0.01億 | 赤縮 | - | | 0.67億 | -21.2% | 137億 | -5.3% |
| 2011/03 | 0 | +100% | - | | 0.54億 | -19.4% | 137億 | -0.2% |
| 2012/03 | 0 | | - | | 0.66億 | +22.2% | 144億 | +5.2% |
| 2013/03 | -62億 | | - | | 1.04億 | +57.6% | 149億 | +3.4% |
| 2014/03 | - | | - | | 1.81億 | +74% | 160億 | +7.5% |
| 2015/03 | - | | - | | 0.89億 | -50.8% | 186億 | +16.3% |
| 2016/03 | - | | - | | 1.25億 | +40.4% | 178億 | -4.7% |
| 2017/03 | - | | - | | 0.88億 | -29.6% | 186億 | +5% |
| 2018/03 | - | | - | | 3.07億 | +248.9% | 170億 | -8.7% |
| 2019/03 | - | | - | | 4.05億 | +31.9% | 179億 | +5.2% |
| 2020/03 | - | | - | | 4.86億 | +20% | 148億 | -17.3% |
| 2021/03 | - | | - | | 6.46億 | +32.9% | 125億 | -15.8% |
| 2022/03 | - | | - | | 13.2億 | +105% | 122億 | -2.1% |
| 2023/03 | - | | - | | 6.89億 | -48% | 122億 | +0.2% |
| 2024/03 | - | | - | | - | | 166億 | +36% |
